Biodesix Inc (NASDAQ:BDSX)’s traded shares stood at 1.88 million during the last session, with the company’s beta value hitting 0.99. At the close of trading, the stock’s price was $0.32, to imply a decrease of -3.15% or -$0.01 in intraday trading. The BDSX share’s 52-week high remains $2.04, putting it -537.5% down since that peak but still an impressive 46.88% since price per share fell to its 52-week low of $0.17.
Analysts have given a consensus recommendation of Buy for Biodesix Inc (BDSX), translating to a mean rating of 1.33. Of 1 analyst(s) looking at the stock, 0 analyst(s) give BDSX a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.
Biodesix Inc (NASDAQ:BDSX) trade information
After registering a -3.15% downside in the last session, Biodesix Inc (BDSX) has traded red over the past five days. The 5-day price performance for the stock is 7.90%, and -11.07% over 30 days. With these gigs, the year-to-date price performance is -79.11%.
The extremes give us $3 and $3 for target low and target high price respectively. As such, BDSX has been trading -837.5% off suggested target high and -837.5% from its likely low.
Biodesix Inc (BDSX) estimates and forecasts
The rating firms project that company’s revenue will grow 14.99% compared to the previous financial year.
Revenue forecast for the current quarter as set by 6 analysts is 18.47M. Meanwhile, for the current quarter, a total of 6 analyst(s) estimate revenue growth to 20.82M.Earnings reports from the last fiscal year show that sales brought in 17.93M and 18.15M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 3.02% before jumping 14.69% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 69.26% for the past 5-year period. While 2025 is set for a 26.46% return in earnings, projections for the next 5 years are at 33.97% annually.
BDSX Dividends
Biodesix Inc has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is SOLEUS CAPITAL MANAGEMENT, L.P. with 6.11 million shares, or about 4.8062% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $9.35 million.
